The newspaper writes:
"...a Burlington doctor in 2010 recommended the family inject Botox as treatment. In an interview with the Burlington Free Press ... [the parents]... argued that Allergan does not properly warn the public of potential dangers of using the product.Botox for pediatric spasticity is not approved by the FDA and is considered an "off-label" use.
When the first dose of Botox did not work, the doctor administered a second, larger dose a few years later, according to court papers. The boy suffered a severe allergic reaction, which included facial swelling, slurred speech, respiratory difficulties, vomiting and seizures, and he was rushed to the emergency room at Fletcher Allen Health Care."
An earlier article provides more information on this lawsuit: Family sues over pediatric Botox treatment.